Physician profile
Gerald Aggrey
NPI 1639564065
$8,716.58
in general payments reported to CMS, 2019-2025
11 companies · $577 in 2025
The $577 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $277 · 2021: $783 · 2022: $1,710 · 2023: $2,002 · 2024: $3,367 · 2025: $577.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,104 · Food and Beverage: $2,841.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,104.49 |
| Food and Beverage | $2,841.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,282.77 | 2020-2025 | Mako, Motionsense Digital Goniometer, Triathlon |
| Zimmer Biomet Holdings, INC. | $3,615.66 | 2022-2025 | Persona, Rosa, Arcos |
| Orthalign INC | $240.00 | 2021-2024 | Orthalign Plus |
| Depuy Synthes Sales INC. | $218.47 | 2020-2024 | Actis |
| Onkos Surgical, INC. | $113.40 | 2022 | |
| Wildwood Medical LLC | $71.45 | 2025 | |
| Heron Therapeutics, INC. | $62.45 | 2025 | Zynrelef |
| Fx Shoulder Solutions, INC | $45.25 | 2024 | |
| Heraeus Medical, LLC. | $24.76 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $23.67 | 2023 | Iovera |
| Sonex Health, INC. | $18.70 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Aggrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.